
51 - 200 funcionários
🧬 Biotecnologia
💊 Farmacêutico
🔥 Investimento no último ano
💰 $500.000.000 Post-IPO Debt - Celcuity em 2025-09
Biotechnology • Pharmaceuticals
A Celcuity é uma empresa de biotecnologia em estágio clínico que desenvolve terapias direcionadas para bloquear de forma abrangente a via PI3K/AKT/mTOR (PAM) no tratamento de múltiplos tumores sólidos. Seu principal candidato a produto, o gedatolisibe, é um potencial inibidor pan-PI3K e mTORC1/2 de primeira classe em desenvolvimento clínico avançado (incluindo ensaios de Fase 3 VIKTORIA) para câncer de mama avançado HR+/HER2- e outras indicações, como câncer de próstata. A empresa avança com um pipeline focado em inibidores da via PAM, publica dados clínicos, envolve-se com investidores e reguladores, e tem como missão melhorar os resultados para pacientes com câncer.
🕒 Abril 21
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

51 - 200 funcionários
🧬 Biotecnologia
💊 Farmacêutico
🔥 Investimento no último ano
💰 $500.000.000 Post-IPO Debt - Celcuity em 2025-09
Biotechnology • Pharmaceuticals
A Celcuity é uma empresa de biotecnologia em estágio clínico que desenvolve terapias direcionadas para bloquear de forma abrangente a via PI3K/AKT/mTOR (PAM) no tratamento de múltiplos tumores sólidos. Seu principal candidato a produto, o gedatolisibe, é um potencial inibidor pan-PI3K e mTORC1/2 de primeira classe em desenvolvimento clínico avançado (incluindo ensaios de Fase 3 VIKTORIA) para câncer de mama avançado HR+/HER2- e outras indicações, como câncer de próstata. A empresa avança com um pipeline focado em inibidores da via PAM, publica dados clínicos, envolve-se com investidores e reguladores, e tem como missão melhorar os resultados para pacientes com câncer.
• Provide leadership and technical guidance for selection, transfer, and management of new CDMO manufacturing activities. • Lead current drug substance manufacturing process and optimize for continuous improvement of material. • Support ongoing CDMO manufacturing activities and troubleshoot issues and non-conformities. • Determine and resolve gaps for regulatory compliance with drug substance manufacturing and development. • Support formulation development with drug substance optimization, impurity identification, and pre-clinical study coverage involvement. • Author and review drug substance IND-enabling protocols, reports, and regulatory submissions. • Engage and support formulation development with new entity optimization and synthetic route creation/advancement. • Produce intellectual patent assessments and complete development projects intended for furthering IP generation. • Other duties as assigned.
• PhD, Master’s, or Bachelor’s degree in a physical science field, ideally chemistry, chemical engineering, or biomanufacturing. • ≥ 8 years in small molecule medicinal chemistry, API development, and/or manufacturing. • Experienced with early development activities including IND-enabling development and authoring. • Managed CDMOs for initial development, manufacturing, process validation, and transfer activities. • Knowledge of analytical technologies including LC, GC, NMR, MS, XRPD, and other relevant methodologies used for elucidation and purity determination. • Well-informed of FDA, EU, and ICH guidelines for drug substance manufacturing and quality assurance. • Excellent written and verbal communication skills, with ability to influence and build credibility at all levels. • Strong interpersonal skills for interacting with employees and leaders across various levels and functions. • Attention to detail and ability to manage multiple processes and documentation requirements. • Highly organized with documentation associated with project planning, communication, and resulting reports. • Strong technical and analytical skills with advanced knowledge in ChemDraw, and MS Office including Word, Excel, and PowerPoint. • Ability to work in a team or independently as required. • Outstanding organizational skills with the ability to prioritize. • Demonstrated independent and sound decision-making skills; ability to think critically and make decisions in a fast-paced environment. • Maintain a positive, approachable and professional attitude.
• Medical insurance • Dental insurance • Vision insurance • 401(k) match • Paid time off • Paid holidays • Annual performance incentive bonus • New hire equity package
Candidatar-se🕒 Abril 21
Associate Director managing clinical development studies at Definium Therapeutics for brain health disorder treatments. Collaborating across functions to deliver high‑quality clinical data.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Abril 20
1001 - 5000
IBM Strategic Relationship Senior Director responsible for managing strategic IBM contracts and go-to-market activities at Ensono. Collaborating across departments to deliver client and shareholder value.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $180.000 - $250.000 / ano
⏰ Tempo Integral
🟠 Sênior
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Abril 18
🕒 Abril 18
10.000+ funcionários
Associate Director managing digital quality management systems and driving change initiatives for BeOne, an oncology company dedicated to affordable cancer treatments.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Abril 18
Oncology Associate Director in Regeneron enhancing engagements with key US Oncology thought leaders. Collaborating with various teams to drive strategic initiatives in Oncology Solid Tumor portfolio.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $157.200 - $256.600 / ano
💰 Post-IPO Equity em 2023-10
⏰ Tempo Integral
🟠 Sênior
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Abril 17
Associate Director in Omnichannel Strategy at Inizio Evoke driving integrated marketing for clients. Collaborating across disciplines to create innovative omnichannel solutions with a focus on healthcare.
🗣️🇺🇸🇬🇧 Inglês obrigatório